Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets

Z Zhang, L Zhao, X Zhou, X Meng, X Zhou - Frontiers in immunology, 2023 - frontiersin.org
Hypertension is regarded as the most prominent risk factor for cardiovascular diseases,
which have become a primary cause of death, and recent research has demonstrated that …

Hypertension as cardiovascular risk factor in chronic kidney disease

M Burnier, A Damianaki - Circulation research, 2023 - ahajournals.org
Hypertension is the leading modifiable cause of premature death and hence one of the
global targets of World Health Organization for prevention. Hypertension also affects the …

European Society of Cardiology: cardiovascular disease statistics 2021

A Timmis, P Vardas, N Townsend… - European heart …, 2022 - academic.oup.com
Aims This report from the European Society of Cardiology (ESC) Atlas Project updates and
expands upon the widely cited 2019 report in presenting cardiovascular disease (CVD) …

Trial of intensive blood-pressure control in older patients with hypertension

W Zhang, S Zhang, Y Deng, S Wu, J Ren… - … England Journal of …, 2021 - Mass Medical Soc
Background The appropriate target for systolic blood pressure to reduce cardiovascular risk
in older patients with hypertension remains unclear. Methods In this multicenter …

Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension

B Zhou, P Perel, GA Mensah, M Ezzati - Nature Reviews Cardiology, 2021 - nature.com
High blood pressure is one of the most important risk factors for ischaemic heart disease,
stroke, other cardiovascular diseases, chronic kidney disease and dementia. Mean blood …

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

ESC Cardiovasc Risk Collaboration… - European Heart …, 2021 - research.rug.nl
Aims The aim of this study was to develop, validate, and illustrate an updated prediction
model (SCORE2) to estimate 10-year fatal and non-fatal cardiovascular disease (CVD) risk …

[HTML][HTML] Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million …

B Zhou, AW Rayner, EW Gregg, KE Sheffer… - The Lancet, 2024 - thelancet.com
Background Diabetes can be detected at the primary health-care level, and effective
treatments lower the risk of complications. There are insufficient data on the coverage of …

[HTML][HTML] Role and mechanism of gut microbiota in human disease

Y Chen, J Zhou, L Wang - Frontiers in cellular and infection …, 2021 - frontiersin.org
The human gut microbiome is a huge microbial community that plays an irreplaceable role
in human life. With the further development of research, the influence of intestinal flora on …

2020 International Society of Hypertension global hypertension practice guidelines

T Unger, C Borghi, F Charchar, NA Khan… - …, 2020 - ahajournals.org
In the Guidelines, differentiation between optimal and essential standards were not always
possible, and were made in sections where it was most practical and sensible. The …

The global epidemiology of hypertension

KT Mills, A Stefanescu, J He - Nature Reviews Nephrology, 2020 - nature.com
Hypertension is the leading cause of cardiovascular disease and premature death
worldwide. Owing to the widespread use of antihypertensive medications, global mean …